What Is A Clinical Trial?
Clinical trials are research studies with the basic aim to provide information as to whether a new medicine, medical device or a biologic is safe and effective when used in humans. The treatment you receive is considered "experimental" and is not yet approved by the Food & Drug Administration. Before you agree to participate, study doctors will review with you all of the risks and possible benefits associated with your experimental treatment.
Ongoing Clinical Trials
Solid Tumor Cancer
In this Phase I trial for subjects with advanced solid cancerous tumors, all subjects will receive open label X-PACT treatment as an intra-tumoral injection. The primary objective will be to establish the safety of X-PACT when dosed with 5 intra-tumoral injections of the combination product (the phosphor device and methoxsalen sterile solution and subsequently exposing the tumor to X-ray energy) over a period of 6 weeks (on day D1, D3 and D5 of Week 1, on D1 of Week 2, and a booster on D1 of Week 6). After the week 8 tumor assessment, subjects demonstrating stable disease, partial response or unconfirmed progression assessed by iRecist, will be eligible to receive two additional booster treatments 4-6 weeks apart.How Do I Participate?
If you would like to be kept informed of new trials or additional types of cancer being treated with X-PACT, please complete the patient form. If you would like information about a specific trial we are currently conducting then click on the study link at clinicaltrials.gov and either email the study coordinator at the site closest to you, or email the Immunolight study contact.